Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT07803341
Active, not recruiting Observational

Clinical and Functional Outcomes After Subtalar Arthroereisis in Pediatric Flexible Flatfoot

NCT07803341 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2026-04-13
Last updated
2026-09-03

Condition(s) studied

Pediatric Flexible Flatfoot

Investigational drug(s) / intervention(s)

Subtalar Arthroereisis

Subtalar Arthroereisis: A conical titanium implant is inserted into the sinus tarsi through a minimally invasive approach to restrict excessive subtalar pronation while preserving joint mobility. Implant size and position are assessed clinically and under fluoroscopic guidance. Additional soft-tissue or navicular procedures may be performed when clinically indicated, including gastrocnemius lengthening; excision or regularization of a symptomatic accessory or prominent navicular; posterior tibial tendon reinsertion or retensioning; or anterior tibial tendon tenosuspension according to the Young technique. These procedures are determined by clinical need and are not assigned by the study protocol.

Study summary

Flexible flatfoot is common in children and adolescents. In some patients, the condition remains painful or limits activity despite non-surgical treatment. Subtalar arthroereisis is a minimally invasive operation in which an implant is placed in the sinus tarsi to limit excessive foot pronation while preserving joint movement.

This observational study follows children and adolescents who receive subtalar arthroereisis as part of their planned clinical care. Clinical status, standing foot radiographs, plantar-pressure distribution, and walking characteristics are assessed before surgery and six months after surgery. The study aims primarily to describe changes in dynamic plantar loading and walking parameters. Changes in clinical scores and radiographic alignment are assessed as secondary outcomes. No treatment is assigned for research purposes, and all surgical and postoperative decisions are made according to routine clinical indications.

Eligibility

Sex
ALL
Min age
10 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Scheduled for elective subtalar arthroereisis, with or without adjunctive surgical procedures. * Aged 10 to 18 years at the time of enrollment. * Male or female. Exclusion Criteria: * Concomitant orthopedic or neurological conditions affecting walking ability. * Neurological or vestibular disorders affecting balance. * Contraindications to the medical devices used in the study. * Inability to understand and sign the informed consent form.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istituto di Cura Città di Pavia Pavia Pavia

More University of Pavia trials in Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07803341 on ClinicalTrials.gov ↗ ← All trials in Italy